Grants and Contributions:
Title:
Novel vascular perfusion analysis in Critical Limb Ischemia
Agreement Number:
983571
Agreement Value:
$50,000.00
Agreement Date:
Nov 30, 2021 - Apr 30, 2022
Description:
Moonrise Medical is a medical device company focused in the development of a unique novel perfusion proof of principle for the optimization of critical limb threatening ischemia to improve wounds and prevent foot amputations
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Oakville, Ontario, CA L6J 1G7
Reference Number:
172-2021-2022-Q3-983571
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
772090403
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 30 days.
Amendment Date
Mar 30, 2022
Recipient's Legal Name:
Moonrise Medical Inc.
Federal Riding Name:
Oakville
Federal Riding Number:
35072
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
33911
Amendments: